Gene Expression Regulation, Neoplastic

Displaying 1 - 4 of 4CSV
Lee, M. K., Azizgolshani, N., Zhang, Z., Perreard, L., Kolling, F. W., Nguyen, L. N., Zanazzi, G. J., Salas, L. A., & Christensen, B. C. (2024). Associations in cell type-specific hydroxymethylation and transcriptional alterations of pediatric central nervous system tumors. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-47943-9
Publication Date
Lee, M. K., Azizgolshani, N., Shapiro, J. A., Nguyen, L. N., Kolling, F. W., Zanazzi, G. J., Frost, H. R., & Christensen, B. C. (2024). Identifying tumor type and cell type-specific gene expression alterations in pediatric central nervous system tumors. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-47712-8
Publication Date
Liu, Y., Wu, Z., Zhou, J., Ramadurai, D. K. A., Mortenson, K. L., Aguilera-Jimenez, E., Yan, Y., Yang, X., Taylor, A. M., Varley, K. E., Gertz, J., Choi, P. S., Cherniack, A. D., Chen, X., Bass, A. J., Bailey, S. D., & Zhang, X. (2021). A predominant enhancer co-amplified with the SOX2 oncogene is necessary and sufficient for its expression in squamous cancer. Nature Communications, 12(1). https://doi.org/10.1038/s41467-021-27055-4
Publication Date